Examiner Afremova Vera

1653-AFREMOVA-VERA

Employment Information

Art Unit:1653 — Chemistry: molecular biology and microbiology
Group:1650 — Enzymology, Microbiology, and Fermentation, Small Peptides and Bioacting Plant, Microbial and Animal Extracts
Classes: 424 — Drug, bio-affecting and body treating compositions
435 — Chemistry: molecular biology and microbiology
426 — Food or edible material: processes, compositions, and products
600 — Surgery
514 — Drug, bio-affecting and body treating compositions
504 — Plant protecting and regulating compositions
252 — Compositions
427 — Coating processes
434 — Education and demonstration
Phone:(571) 272-0914
Email:vera.afremova@uspto.gov
Location:VA 22314
Title:Pat Examnr Biolgy
Service:29 years
Grade:GS-14

Grant Rate and Difficulty Ranking

90
3-Year Grant rate: 32% over 419 cases
Difficulty: Very Hard
Difficulty Percentile: 90th

With Examiner Afremova, you have a 32% chance of getting an issued patent by 3 years after the first office action. Examiner Afremova is a very hard examiner and in the 90th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Afremova, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1653

Examiner Afremova's grant rate is lower than that of Art Unit 1653 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Afremova 2.4
Art Unit 1653 2.2

Interview Benefit

Grant Rate without Interview

Examiner Afremova has granted 86 of 342 cases without any applicant-requested interviews for a grant rate of 25%.

Grant Rate with Interview

Examiner Afremova has granted 47 of 77 cases with at least one applicant-requested interview for a grant rate of 61%.

Interview Benefit

With Examiner Afremova, conducting an interview increases your chance of getting a patent granted by 144%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
17273004 Methods Of Continuous Cell Culture Rejection information available with a Premium Stats subscription. See our pricing. Patented View
18025944 Probiotic Compositions For The Treatment Of Acne Patented View
18831490 Prebiotic And Probiotic Formulation Containing Acid And Heat Resistant Bacteria Abandoned View
17597177 Antiproliferative Effect Of Agarophyton Chilensis Extract In Prostate Cancer Patented View
18864872 Feed Additive Comprising Enzyme Combinations Abandoned View
16443658 Methods For Producing Rich Cell Culture Media Using Chemoautotrophic Microbes Abandoned View
17368601 Microbial Biomass-Based Feed Products Abandoned View
18862460 Engineered Microorganisms With Enhanced Protein Expression And Secretion Abandoned View
16302624 Compositions And Uses Thereof Patented View
19126369 Prevention Of Post-Operative Atrial Fibrillation With A Botulinum Toxin Abandoned View
18709066 Smart Chemo-Enzymatic Color Change Label And Expiration Date Of Food, Pharmaceutical, And Biological Products Abandoned View
18023287 Method And System For Studying Objects, In Particular Biological Cells Abandoned View
19175417 Ammonia Oxidizing Microorganisms For Ph Modulation Abandoned View
18618941 Probiotic Supplement For Metabolic Health Abandoned View
16839995 Methods And Compositions For Treating Atopic Dermatitis With Recombinant Microorganisms Abandoned View
18459983 Methods For Treating A Health Condition With Probiotics Patented View
17698490 Viable Lyophilized Compositions Derived From Human Tissues And Methods Of Making The Same Abandoned View
18849609 Daily Use Preservative-Free Cosmetic Compositions Abandoned View
17420177 Supplemented Serum-Containing Culture Medium For Enhanced Arpe-19 Growth And Human Cytomegalovirus Vaccine Production Abandoned View
16755270 Tolerance Of Microbial Cells Against Ortho-Aminobenzoate In Presence Of Alkali Ions At Neutral Ph Abandoned View
18372656 Strains Of Lactobacillus Delbrueckii Which Inhibit Porphyromonas Gingivalis Patented View
16646687 Metabolomic Revision Of Mammalian Infants Abandoned View
18703189 Drug Product Surrogate Solutions Abandoned View
17950391 Algal Botanical Extracts Rich In Eicosapentaenoic Acid As Tri/diglyceride Conjugate Abandoned View
17547361 Probiotic Sports Nutrition Compositions Abandoned View
17431346 Liquid Fertilizer Production Method And Highquality Liquid Fertilizer Based On L F Q C And Chlorella Microbiological Fertilizer Manufacture Method Abandoned View
17953610 Postbiotic Compositions And Related Methods For Agriculture Abandoned View
18132565 Composition For Promoting Absorption Of Phytochemicals Abandoned View
17907523 Deterministic Lateral Displacement Array With A Single Column Of Bumping Obstacles Abandoned View
17815530 Microorganisms Converting Inositol To Butyrate Abandoned View
17807077 Biopesticide Composition For Use In Preventing Or Minimizing Plant Disease Abandoned View
18835535 Methods And Applications Of Analyzing The Perfusate Of An Ex Situ Perfused Kidney Abandoned View
18683440 System And Method For Cultivating And Harvesting Cyanobacterial Biomass Abandoned View
17595616 Use Of Enzyme That Cleaves Both Alpha- And Beta-1,4-Glycosidic Bonds Patented View
17795764 Composition Of Microorganisms For Breeding Insects Abandoned View
18682564 Methods And Compositions For Aquaculture Abandoned View
17279293 Immunostimulator And Method For Preventing Infection Abandoned View
18137752 Dietary Supplement Patented View
18836109 Compositions And Methods Of Affecting Cytokine Levels Using Prevotella Histicola Abandoned View
16771866 Water-Reconstitutable Culture Medium Resistant To Liquefaction By Microorganisms Patented View
17069641 Diagnosis And Treatment Of Invasive Aspergillosis Abandoned View
16992865 Method For Detection And Mitigation Of Compound Producing Microbiota In An Aquaculture System Abandoned View
18621769 Rapid Isolation, Cultivation Methods And Utilities Of Truffle Fungi Patented View
18547714 Antibody Recruitment Molecules And Methods Of Treating Cancer Using Same Abandoned View
18251117 Polypeptide Compositions And Methods For Use Abandoned View
17632497 Engineered Biosynthetic Pathways For Production Of 3-Amino-4-Hydroxybenzoic Acid By Fermentation Abandoned View
17769268 Compositions Comprising Hyaluronidase And/or Collagenase And/or 4-Methylumbelliferone (4-Mu) And Methods Of Treatment Using Same Abandoned View
18273420 Compositions And Methods For Treating Hepatic Encephalopathy Abandoned View
18288978 The Polarity And Specificity Of Sars-Cov2 -Specific T Lymphocyte Responses As A Biomarker Of Disease Susceptibility Abandoned View
18570964 Topical Probiotic Delivery System Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...